Antimicrobial peptides: therapeutic potential
A significant component of the innate immune system of a wide variety of animals and plants is arbitrated by cationic host defence peptides. In man, these peptides, in addition to exhibiting a direct antimicrobial activity, seems to provide a range of non-antimicrobial bioactivities related to defen...
Saved in:
| Published in | Expert opinion on pharmacotherapy Vol. 7; no. 6; p. 653 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.04.2006
|
| Subjects | |
| Online Access | Get more information |
Cover
Loading…
| Abstract | A significant component of the innate immune system of a wide variety of animals and plants is arbitrated by cationic host defence peptides. In man, these peptides, in addition to exhibiting a direct antimicrobial activity, seems to provide a range of non-antimicrobial bioactivities related to defence, inflammation and wound healing. Despite the fact that such peptides have so far failed to reach the market, there are continued initiatives to advance such potential therapeutics to, and through, the clinic. The reasons behind such initiatives include: reduced manufacturing costs for peptides; allowing entry into therapeutic areas previously inaccessible due to cost; the continued identification of previously unknown bioactivities of such peptides; and the resurgence of interest in peptide therapeutics. As a result, clinical programmes based on cationic host defence peptides exist in the areas of infection, dermatology, cancer and inflammation. The probability of clinical success for host defence peptide-based therapeutics is on the rise as options for a wider range of clinical indications emerge. |
|---|---|
| AbstractList | A significant component of the innate immune system of a wide variety of animals and plants is arbitrated by cationic host defence peptides. In man, these peptides, in addition to exhibiting a direct antimicrobial activity, seems to provide a range of non-antimicrobial bioactivities related to defence, inflammation and wound healing. Despite the fact that such peptides have so far failed to reach the market, there are continued initiatives to advance such potential therapeutics to, and through, the clinic. The reasons behind such initiatives include: reduced manufacturing costs for peptides; allowing entry into therapeutic areas previously inaccessible due to cost; the continued identification of previously unknown bioactivities of such peptides; and the resurgence of interest in peptide therapeutics. As a result, clinical programmes based on cationic host defence peptides exist in the areas of infection, dermatology, cancer and inflammation. The probability of clinical success for host defence peptide-based therapeutics is on the rise as options for a wider range of clinical indications emerge. |
| Author | Falla, Timothy J Zhang, Lijuan |
| Author_xml | – sequence: 1 givenname: Lijuan surname: Zhang fullname: Zhang, Lijuan email: lzhang@helixbiomedix.com organization: Helix Biomedix, Inc., Bothell, WA 98021, USA. lzhang@helixbiomedix.com – sequence: 2 givenname: Timothy J surname: Falla fullname: Falla, Timothy J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16556083$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1jktLw0AURgdR7EP3riR_IHHeM3FXilWh0E1dl5s7NziSx5BMF_57Cyrf4mwOh2_FrodxIMYeBK-EEe5JaGsus5WrbGWNumJL4bQunbV2wVbz_MW55LXRt2whrDGWe7Vk5WbIsY84jU2ErkiUcgw0Pxf5kyZIdM4RizRmumjQ3bGbFrqZ7v-4Zh-7l-P2rdwfXt-3m32JmvNc1hi0JqHaRkkuG8AaQEo0bctNUAGUtsgDYQBwKBT64L3ypLB2HpwUcs0ef7vp3PQUTmmKPUzfp__f8gdjH0Uo |
| CitedBy_id | crossref_primary_10_1155_2021_8822161 crossref_primary_10_1186_cc11220 crossref_primary_10_1038_nbt1267 crossref_primary_10_1007_s10989_009_9182_3 crossref_primary_10_1088_0957_4484_22_50_505103 crossref_primary_10_1021_acs_jpclett_6b01622 crossref_primary_10_1016_j_biochi_2011_08_011 crossref_primary_10_1586_14787210_6_6_887 crossref_primary_10_1016_j_peptides_2011_01_026 crossref_primary_10_1007_s00726_014_1820_1 crossref_primary_10_1002_psc_1185 crossref_primary_10_1007_s00109_009_0508_6 crossref_primary_10_3390_app10207089 crossref_primary_10_1016_j_bpj_2008_11_053 crossref_primary_10_1002_bip_23276 crossref_primary_10_1002_cbic_201600381 crossref_primary_10_1007_s11274_013_1575_y crossref_primary_10_1128_AAC_00686_17 crossref_primary_10_1096_fj_09_145474 crossref_primary_10_1007_s12602_012_9098_7 crossref_primary_10_1002_pep2_24041 crossref_primary_10_1007_s11095_007_9501_3 crossref_primary_10_3390_ijms10093951 crossref_primary_10_1097_SHK_0b013e318160de11 crossref_primary_10_1016_j_jddst_2017_12_010 crossref_primary_10_2119_2008_00002_Steinstraesser crossref_primary_10_1007_s10096_011_1233_y crossref_primary_10_1002_wnan_126 crossref_primary_10_1016_j_clindermatol_2009_05_013 crossref_primary_10_1021_ar700270t crossref_primary_10_1097_SLA_0000000000002186 crossref_primary_10_1128_AAC_01790_09 crossref_primary_10_1016_j_bmcl_2017_11_034 crossref_primary_10_1016_j_nano_2007_06_002 crossref_primary_10_1556_MOnkol_54_2010_1_7 crossref_primary_10_1128_AAC_00635_07 crossref_primary_10_1016_j_biochi_2009_07_007 crossref_primary_10_1172_JCI38842 crossref_primary_10_1007_s00109_006_0143_4 crossref_primary_10_1016_j_chembiol_2006_10_001 crossref_primary_10_1039_c2ra01351g crossref_primary_10_1007_s00726_012_1261_7 crossref_primary_10_1016_j_biotechadv_2016_05_007 crossref_primary_10_1016_j_ejmech_2018_03_027 crossref_primary_10_1371_journal_pone_0143583 crossref_primary_10_1080_13543776_2017_1261113 crossref_primary_10_1007_s10989_017_9580_x crossref_primary_10_1186_1471_2180_10_253 crossref_primary_10_1517_13543776_2014_876993 crossref_primary_10_1590_S1516_05722013000200003 crossref_primary_10_3389_fmicb_2018_02277 crossref_primary_10_1007_s00232_024_00306_3 crossref_primary_10_1039_b912533g crossref_primary_10_3762_bjoc_8_237 crossref_primary_10_1016_j_bmcl_2015_04_092 crossref_primary_10_1016_j_bmcl_2018_10_001 crossref_primary_10_1016_j_cbi_2010_04_012 crossref_primary_10_1517_13543776_2011_551116 crossref_primary_10_1016_j_biotechadv_2014_12_003 crossref_primary_10_3390_ijms12095971 crossref_primary_10_3390_ijms12106566 crossref_primary_10_1002_cbic_201300034 crossref_primary_10_1371_journal_pone_0127584 crossref_primary_10_3390_polym14183791 crossref_primary_10_3390_ijms21197047 crossref_primary_10_1016_j_peptides_2007_12_012 crossref_primary_10_1080_10408410802143808 crossref_primary_10_1016_j_bbamem_2018_05_004 crossref_primary_10_1016_j_dci_2024_105207 crossref_primary_10_1039_c0md00247j crossref_primary_10_1002_jgm_1287 crossref_primary_10_1093_jb_mvn134 crossref_primary_10_1039_b810403d crossref_primary_10_1007_s12275_021_0649_z crossref_primary_10_1111_j_1524_475X_2012_00786_x crossref_primary_10_1016_j_bbamem_2014_04_015 crossref_primary_10_1016_j_biochi_2015_07_014 crossref_primary_10_1039_b904746h crossref_primary_10_1586_14787210_2014_976613 crossref_primary_10_1007_s00404_023_07200_8 crossref_primary_10_1111_jfd_12497 crossref_primary_10_1080_07391102_2012_691363 crossref_primary_10_1186_cc11920 crossref_primary_10_2174_1570163816666190620114338 crossref_primary_10_3390_ph16101356 crossref_primary_10_1016_j_ejmech_2015_10_015 crossref_primary_10_1039_b900278m crossref_primary_10_1002_slct_201600947 crossref_primary_10_1007_s00253_018_8982_9 crossref_primary_10_3390_molecules23071513 crossref_primary_10_3390_antibiotics8030130 crossref_primary_10_1016_j_nano_2008_11_001 crossref_primary_10_1071_EA07185 crossref_primary_10_1002_psc_2970 crossref_primary_10_1002_psc_876 crossref_primary_10_1016_j_aquaculture_2020_736132 crossref_primary_10_1093_femsre_fux012 crossref_primary_10_1111_febs_12349 crossref_primary_10_1111_j_1582_4934_2011_01406_x crossref_primary_10_1128_CMR_00056_05 crossref_primary_10_1021_acschembio_6b00910 crossref_primary_10_1007_s10989_020_10127_2 crossref_primary_10_1097_COC_0b013e31815e456d crossref_primary_10_1021_jo201358e crossref_primary_10_1016_j_peptides_2007_09_010 crossref_primary_10_1016_j_arcmed_2021_08_001 crossref_primary_10_1016_j_tifs_2019_04_002 crossref_primary_10_1007_s12033_021_00325_8 crossref_primary_10_1016_j_bbamem_2014_07_028 crossref_primary_10_1093_nar_gku1141 crossref_primary_10_1016_j_peptides_2010_07_027 crossref_primary_10_3390_ijms18020339 crossref_primary_10_1111_j_1574_695X_2012_00954_x |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1517/14656566.7.6.653 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1744-7666 |
| ExternalDocumentID | 16556083 |
| Genre | Journal Article Review |
| GroupedDBID | --- 00X 03L 0BK 0R~ 29G 4.4 53G 5GY AAMIU AAOUU AAPWH ABBAB ABEIZ ABJNI ABJYH ABLIJ ABLKL ABVAX ABXYU ACGFS ACIEZ ADCVX ADRBQ ADTOD AECIN AENEX AEOZL AGDLA AGMLL AIJEM AIRBT AIYSM AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU BABNJ BLEHA CAZVN CCCUG CGR CKQYL CS3 CUY CVF DASJU DAWQK DKSSO DU5 EBS ECM EIF EJD EMOBN F5P H13 HZ~ KRBQP KSSTO KUULJ KWAYT KYCEM LJTGL LSO M44 M4Z NPM O9- P2P RNANH TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TZHSB V1S ~1N |
| ID | FETCH-LOGICAL-c400t-9cd44e13fb3202bac9aa22c5ff05d3da346c0decdaa7c13c8d8838e3c978a7212 |
| IngestDate | Tue Oct 15 23:31:02 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c400t-9cd44e13fb3202bac9aa22c5ff05d3da346c0decdaa7c13c8d8838e3c978a7212 |
| PMID | 16556083 |
| ParticipantIDs | pubmed_primary_16556083 |
| PublicationCentury | 2000 |
| PublicationDate | 2006-Apr |
| PublicationDateYYYYMMDD | 2006-04-01 |
| PublicationDate_xml | – month: 04 year: 2006 text: 2006-Apr |
| PublicationDecade | 2000 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Expert opinion on pharmacotherapy |
| PublicationTitleAlternate | Expert Opin Pharmacother |
| PublicationYear | 2006 |
| SSID | ssj0020954 |
| Score | 2.2010787 |
| SecondaryResourceType | review_article |
| Snippet | A significant component of the innate immune system of a wide variety of animals and plants is arbitrated by cationic host defence peptides. In man, these... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 653 |
| SubjectTerms | Animals Anti-Infective Agents - metabolism Anti-Infective Agents - therapeutic use Antimicrobial Cationic Peptides - metabolism Antimicrobial Cationic Peptides - therapeutic use Humans Technology, Pharmaceutical - trends |
| Title | Antimicrobial peptides: therapeutic potential |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/16556083 |
| Volume | 7 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZ4LCyI9xtlQF1ahyR2XmwVoqoQVB1aqVtlO4nUSk0jCEP59ZwT59EAUmFJonNsOf6c0935HgjdEYsDnREcGdzD1DEZZoRw7FOLOSDPMpfJ2OHXgdMf0-eJPSkKjKvokpTr4vPHuJL_oAo0wFVGyf4B2XJQIMAz4AtXQBiuG2HcjdPZYpalUpIBVdJBJch93GphVe1kmUqXIDXYvPS9C9_StgyXykTGuJ2oJNbpep6B0qL8Mpt_VFupJw3wNbDV8VLNflC6nYQ5z3Mpxa6TFz8pmKJbw77O4Jw8te83xmubKnQ_ExB1V3f0xqvw8ckiA8J0bJCzvA1aG6mwi6ZttO16kqkNpGlGadcgK1J1Dg2TuW9ORWaHVd0bGkQmSYwO0L5SAbRujuch2grjI9Qa5su_6mijCrv3jtbShlV28dUxwmugawXoD1oNcq2E_ASNe0-jxz5WNS-wAG6aYl8ElIYmibgsbM-Z8BmzLGFHkWEHJGCEOsIIQhEw5gqTCC_wPOKFRPiux0Cbt07RTryMw3OkmUEEsh_lgkWcCnmzhAm9LSCbhmAX6CxfhmmSJzaZFgt0-WvLFdqr9tA12o3gTwpvQCxL-W0Gxxcnizg1 |
| link.rule.ids | 783 |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+peptides%3A+therapeutic+potential&rft.jtitle=Expert+opinion+on+pharmacotherapy&rft.au=Zhang%2C+Lijuan&rft.au=Falla%2C+Timothy+J&rft.date=2006-04-01&rft.eissn=1744-7666&rft.volume=7&rft.issue=6&rft.spage=653&rft_id=info:doi/10.1517%2F14656566.7.6.653&rft_id=info%3Apmid%2F16556083&rft_id=info%3Apmid%2F16556083&rft.externalDocID=16556083 |